Holen Sie sich die Stockscreener-App
67.16
2.82%
1.84
Handel nachbörslich:
67.16
Schlusskurs vom Vortag:
$65.32
Offen:
$65.94
24-Stunden-Volumen:
87,070
Relative Volume:
1.36
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.08%
1M Leistung:
+20.57%
6M Leistung:
+21.64%
1J Leistung:
+62.89%
1-Tages-Spanne:
$65.82
$67.17
1-Wochen-Bereich:
$63.86
$67.25
52-Wochen-Spanne:
$40.77
$67.25
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
State Street Spdr S P Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
67.16 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
S&P 500 equity funding costs squeeze past 99th percentile in 'mid-year heatwave' - Seeking Alpha
S&P 500 Stocks Trading At 52-Week High - Trefis
Market Movers | Winners: TRNR, DCOY, ATLN | Losers: BJDX, EVMN, CELZ - Trefis
ValuEngine Weekly Market Summary And Commentary - Seeking Alpha
My S&P 500 Prediction On Sector Outperformers Underperformers For 2H/2026 (NYSEARCA:IVV) - Seeking Alpha
Stock Market Today: Dow Jones, S&P 500 Futures Gain As Trump Admin Says US, Iran Will 'Stand Down'Stat - Benzinga
5 Ways To Protect Capital When SPY/QQQ Tumble, Plus A Simple 2-ETF Mix (NYSEARCA:SPY) - Seeking Alpha
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Large Cap Stocks Trading At 52-Week High - Trefis
Market Movers | Winners: IVF, LVWR, ARL | Losers: CELZ, TVRD, KUST - Trefis
Healthcare stocks have become a haven for investors ditching tech - MSN
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech - AOL.com
Lilly, J&J, AbbVie hit all-time highs as healthcare outperforms - Seeking Alpha
SELLAS Life Sciences (NASDAQ:SLS) rises as short interest builds, company files change-control ahead of AML update - TechStock²
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0590 - MSN
Passive Investing May Have Broken The Market (SP500) - Seeking Alpha
Small Cap Stocks Trading At 52-Week High - Trefis
Mid Cap Stocks Trading At 52-Week High - Trefis
Midday Need to Know: Crude oil slides, housing bill signing postponed & more (SPY:NYSEARCA) - Seeking Alpha
10 large-cap U.S. stocks showing the weakest momentum (SPY:NYSEARCA) - Seeking Alpha
S&P 500 Mid-Year Outlook: Why 7,795 Remains My 2026 Price Target (NYSEARCA:SPY) - Seeking Alpha
Why The S&P 500 Shrugged Off The Iran WarAnd What Could Finally Break The Rally (NYSEARCA:SPY) - Seeking Alpha
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
10 large-cap U.S. stocks with the strongest momentum grades - Seeking Alpha
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Midday Need to Know: AbbVie to buy Apogee, Micron partners with Anthropic & more (SPY:NYSEARCA) - Seeking Alpha
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - AOL.com
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - Yahoo Finance
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 - 24/7 Wall St.
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar. - 24/7 Wall St.
XBI: A "Hidden" ETF Up +70% In 1 Year. (NYSEARCA:XBI) - Seeking Alpha
It Is Wise To Get Cautious Here. Fortunately, There Are Options - Seeking Alpha
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Midday Need to Know: Intel and Apple partner, U.S. dollar climbs & more (SPY:NYSEARCA) - Seeking Alpha
Trevi Therapeutics Inc (TRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
JEPQ: No Reason To Hold It (NASDAQ:JEPQ) - Seeking Alpha
Prestige Consumer Healthcare Inc (PBH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Crinetics Pharmaceuticals Inc (CRNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
June FOMC Statement: Contrarian Perspective On The Expected Rate Hike (SP500) - Seeking Alpha
Royalty Pharma PLC (RPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elanco Animal Health Inc (ELAN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ocular Therapeutix Inc (OCUL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cassava Sciences Inc (SAVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der State Street Spdr S P Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für State Street Spdr S P Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):